OVs expressing cytokines like GM-CSF, TNF, IFN-a/b, IL-2, IL-7, IL-12, IL-15, IL-18, IL23, IL-24, and FLT3L have shown enhanced anti-tumor immune responses and tumor reduction in multiple preclinical cancer models and clinical trials [79]. The gene discussed is IL2; the disease is neoplasm.